Sanofi, drugmaker behind Zantac, has agreed to settle 4,000 lawsuits The suits claim that discontinued Zantac contained cancer-causing chemicals READ MORE: Has heartburn pill that has been given ...

Lawsuits against the companies in the U.S. began piling up in both state and federal courts after the U.S. Food and Drug Administration in 2020 asked manufacturers to pull Zantac off the market.

But, of course, none of that has anything to do with Zantac. Nothing to see here, folks. Move along! As almost everyone knows, the manufacturers of COVID-19 vaccines are immune from lawsuits until ...

Ranitidine was also widely available in generic form from several manufacturers before the NDMA contamination was identified and the FDA banned sales in 2020. The link with cancer has been ...

The FDA banned sales of ranitidine in 2020 over possible contamination with the suspected carcinogen N-nitrosodimethylamine (NDMA. Some manufacturers of the drug voluntarily suspended sales in ...

ranitidine, had the potential to turn into a substance that may trigger cancer when exposed to heat. This led to a wave of lawsuits against the drug's manufacturers. The size of the settlement ...

In April 2020, the FDA requested that manufacturers cease selling Zantac and any generic alternatives. The complaint alleges that during the class period, defendants misrepresented the reasons it ...

Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSE: GSK) between February 5, 2020 and August 14, ...